Switching Roles of TGF-β in Cancer Development: Implications for Therapeutic Target and Biomarker Studies

被引:22
|
作者
Sun, Nan [1 ]
Taguchi, Ayumu [2 ]
Hanash, Samir [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA
来源
JOURNAL OF CLINICAL MEDICINE | 2016年 / 5卷 / 12期
关键词
TGF-beta; targeted therapy; role switch; biomarker; GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; SQUAMOUS-CELL CARCINOMA; BREAST-CANCER; SIGNALING PATHWAY; TUMOR-SUPPRESSOR; C-MYC; DISABLED-2; DAB2; MAMMARY-TUMORS; MIR-200; FAMILY;
D O I
10.3390/jcm5120109
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
TGF-beta induces complicated and even opposite responses in numerous biological processes, e.g., tumor suppression in pre-malignant cells and metastasis promotion in cancer cells. However, the cellular contextual determinants of these different TGF-beta roles remain elusive, and the driver genes triggering the determinants' changes have not been identified. Recently, however, several findings have provided new insights on the contextual determinants of Smads in TGF-beta's biological processes. These novel switches and their effectors may serve as prognostic biomarkers and therapeutic targets of TGF-beta-mediated cancer progression.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] TGF-β in cancer and as a therapeutic target
    Pinkas, Jan
    Teicher, Beverly A.
    BIOCHEMICAL PHARMACOLOGY, 2006, 72 (05) : 523 - 529
  • [2] Therapeutic Implications of the TGF-β System
    Arrick, Bradley A.
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 1996, 1 (04) : 391 - 397
  • [3] The dynamic roles of TGF-β in cancer
    Meulmeester, Erik
    ten Dijke, Peter
    JOURNAL OF PATHOLOGY, 2011, 223 (02): : 205 - 218
  • [4] Roles of TGF- β in cancer hallmarks and emerging onco-therapeutic design
    Dai, Xiaofeng
    Hua, Dong
    Lu, Xiaoxia
    EXPERT REVIEWS IN MOLECULAR MEDICINE, 2022, 24
  • [5] The Role of TGF-β Signaling Pathways in Cancer and Its Potential as a Therapeutic Target
    Yang, Yun
    Ye, Wen-Long
    Zhang, Ruo-Nan
    He, Xiao-Shun
    Wang, Jing-Ru
    Liu, Yu-Xuan
    Wang, Yi
    Yang, Xue-Mei
    Zhang, Yu-Juan
    Gan, Wen-Juan
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [6] Dichotomous roles of TGF-β in human cancer
    Huang, Jennifer J.
    Blobe, Gerard C.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2016, 44 : 1441 - 1454
  • [7] TGF-β Pathway as a Therapeutic Target in Bone Metastases
    Juarez, Patricia
    Guise, Theresa A.
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (11) : 1301 - 1312
  • [8] Proactive and reactive roles of TGF-ß in cancer
    Kuburich, Nick A.
    Sabapathy, Thiru
    Demestichas, Breanna R.
    Maddela, Joanna Joyce
    den Hollander, Petra
    Mani, Sendurai A.
    SEMINARS IN CANCER BIOLOGY, 2023, 95 : 120 - 139
  • [9] Loss of the type Ill TGF-β receptor during cancer progression generates an immunotolerant tumor microenvironment: Translational implications for TGF-β inhibition and immunotherapy biomarker development
    Hanks, Brent A.
    Holtzhausen, Alisha
    Gimpel, Petra
    Campbell, Olivia
    Jamieson, Rebekah
    Ling, Leona E.
    Morse, Michael A.
    Lyerly, H. K.
    Blobe, Gerard
    CANCER RESEARCH, 2012, 72
  • [10] Autophagy as a Therapeutic Target for Chronic Kidney Disease and the Roles of TGF-β1 in Autophagy and Kidney Fibrosis
    Ruby, Miss
    Gifford, Cody C. C.
    Pandey, RamendraPati
    Raj, V. Samuel
    Sabbisetti, Venkata S. S.
    Ajay, Amrendra K. K.
    CELLS, 2023, 12 (03)